Elevation of fecal eosinophil‐derived neurotoxin in infants with food protein‐induced enterocolitis syndrome

1. Sampson HA, Gerth van Wijk R, BindslevJensen C, et al. Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology–European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy ClinImmunol 2012: 130: 1260–74. 2. Bindslev-Jensen C, Ballmer-Weber BK, Bengtsson U, et al. Standardization of food challenges in patients with immediate reactions to foods–position paper from the European Academy of Allergology and Clinical Immunology. Allergy 2004: 59: 690–7. 3. Vlieg-Boerstra BJ, Bijleveld CMA, van der Heide S, et al. Development and validation of challenge materials for double-blind, placebo-controlled food challenges in children. J Allergy ClinImmunol 2004: 113: 341–6. 4. Vlieg-Boerstra BJ, van der Heide S, Bijleveld CM, Kukler J, Duiverman EJ, Dubois AE. Placebo reactions in double-blind, placebocontrolled food challenges in children. Allergy 2007: 62: 905–12. 5. Taylor SL, Hefle SL, Bindslev-Jensen C, et al. A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much? Clin Exp Allergy 2004: 34: 689–95. 6. van der Zee T, Dubois A, Kerkhof M, van der Heide S, Vlieg-Boerstra B. The eliciting dose of peanut in double-blind, placebocontrolled food challenges decreases with increasing age and specific IgE level in children and young adults. J Allergy ClinImmunol 2011: 128: 1031–6.